nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—Epinephrine—TNF—liver cancer	0.00016	0.525	CrCbGaD
Norepinephrine—Isoprenaline—CYP1A1—liver cancer	0.000145	0.475	CrCbGaD
Norepinephrine—CYP1A2—Metabolism—GSTP1—liver cancer	5.37e-05	5.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RAF1—liver cancer	5.36e-05	5.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HRAS—liver cancer	5.35e-05	5.35e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—KRAS—liver cancer	5.34e-05	5.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	5.32e-05	5.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1B—liver cancer	5.31e-05	5.31e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMOX1—liver cancer	5.3e-05	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HRAS—liver cancer	5.28e-05	5.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RAF1—liver cancer	5.28e-05	5.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—liver cancer	5.25e-05	5.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	5.25e-05	5.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK8—liver cancer	5.25e-05	5.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	5.24e-05	5.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MTOR—liver cancer	5.24e-05	5.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—liver cancer	5.24e-05	5.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—BRAF—liver cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	5.2e-05	5.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—liver cancer	5.2e-05	5.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	5.2e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL2—liver cancer	5.2e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	5.2e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1B—liver cancer	5.19e-05	5.2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—liver cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—liver cancer	5.16e-05	5.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MTOR—liver cancer	5.15e-05	5.16e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	5.15e-05	5.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL2—liver cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—liver cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—KRAS—liver cancer	5.14e-05	5.14e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—liver cancer	5.14e-05	5.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—liver cancer	5.12e-05	5.12e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—liver cancer	5.11e-05	5.11e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—liver cancer	5.09e-05	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CB—liver cancer	5.09e-05	5.09e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL2—liver cancer	5.08e-05	5.08e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCND1—liver cancer	5.07e-05	5.07e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—liver cancer	5.06e-05	5.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—JUN—liver cancer	5.06e-05	5.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—liver cancer	5.02e-05	5.02e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CTNNB1—liver cancer	5.02e-05	5.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—JUN—liver cancer	5.01e-05	5.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—liver cancer	5e-05	5e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	4.97e-05	4.97e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—liver cancer	4.96e-05	4.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—JUN—liver cancer	4.95e-05	4.95e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—liver cancer	4.94e-05	4.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—liver cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—liver cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	4.91e-05	4.92e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CTNNB1—liver cancer	4.91e-05	4.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	4.9e-05	4.91e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—liver cancer	4.9e-05	4.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	4.88e-05	4.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—liver cancer	4.87e-05	4.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RAF1—liver cancer	4.87e-05	4.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	4.86e-05	4.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	4.86e-05	4.86e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—liver cancer	4.85e-05	4.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	4.84e-05	4.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	4.83e-05	4.84e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	4.83e-05	4.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—liver cancer	4.82e-05	4.82e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—liver cancer	4.81e-05	4.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—liver cancer	4.81e-05	4.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—liver cancer	4.8e-05	4.8e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—liver cancer	4.79e-05	4.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—liver cancer	4.79e-05	4.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	4.78e-05	4.79e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK8—liver cancer	4.78e-05	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—liver cancer	4.78e-05	4.78e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—liver cancer	4.77e-05	4.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—liver cancer	4.75e-05	4.75e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MTOR—liver cancer	4.75e-05	4.75e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—liver cancer	4.75e-05	4.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—liver cancer	4.74e-05	4.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	4.74e-05	4.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—liver cancer	4.73e-05	4.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	4.73e-05	4.73e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	4.72e-05	4.73e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—liver cancer	4.71e-05	4.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RAF1—liver cancer	4.69e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—liver cancer	4.69e-05	4.69e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK8—liver cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—liver cancer	4.68e-05	4.68e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—liver cancer	4.67e-05	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	4.64e-05	4.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—liver cancer	4.61e-05	4.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—liver cancer	4.6e-05	4.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	4.58e-05	4.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MTOR—liver cancer	4.58e-05	4.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	4.57e-05	4.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—liver cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—liver cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—liver cancer	4.48e-05	4.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	4.46e-05	4.47e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—liver cancer	4.46e-05	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—liver cancer	4.46e-05	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—liver cancer	4.45e-05	4.45e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	4.43e-05	4.43e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—liver cancer	4.42e-05	4.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	4.42e-05	4.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—liver cancer	4.41e-05	4.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	4.39e-05	4.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	4.38e-05	4.38e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—liver cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—liver cancer	4.37e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—liver cancer	4.36e-05	4.37e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MTHFR—liver cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RAF1—liver cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	4.35e-05	4.35e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—liver cancer	4.34e-05	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—liver cancer	4.33e-05	4.33e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—liver cancer	4.32e-05	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	4.3e-05	4.3e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARA—liver cancer	4.28e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—liver cancer	4.28e-05	4.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—liver cancer	4.25e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MTOR—liver cancer	4.25e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	4.25e-05	4.26e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	4.25e-05	4.25e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—liver cancer	4.25e-05	4.25e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CTNNB1—liver cancer	4.21e-05	4.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—liver cancer	4.21e-05	4.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—liver cancer	4.2e-05	4.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—liver cancer	4.18e-05	4.18e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—liver cancer	4.13e-05	4.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—liver cancer	4.12e-05	4.12e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—liver cancer	4.12e-05	4.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—liver cancer	4.1e-05	4.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—liver cancer	4.09e-05	4.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	4.09e-05	4.09e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—liver cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	4.06e-05	4.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—liver cancer	4.05e-05	4.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—liver cancer	4.05e-05	4.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—liver cancer	4.03e-05	4.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	4.02e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK8—liver cancer	4.02e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	4.02e-05	4.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—liver cancer	4.01e-05	4.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	3.99e-05	3.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—liver cancer	3.98e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—liver cancer	3.98e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—liver cancer	3.97e-05	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	3.97e-05	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—liver cancer	3.97e-05	3.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	3.95e-05	3.95e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—liver cancer	3.93e-05	3.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—liver cancer	3.91e-05	3.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—liver cancer	3.91e-05	3.91e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—liver cancer	3.89e-05	3.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	3.87e-05	3.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	3.86e-05	3.86e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.84e-05	3.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—liver cancer	3.82e-05	3.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—liver cancer	3.81e-05	3.81e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—liver cancer	3.8e-05	3.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	3.79e-05	3.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	3.77e-05	3.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—liver cancer	3.76e-05	3.76e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—liver cancer	3.75e-05	3.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	3.75e-05	3.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—liver cancer	3.72e-05	3.72e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—liver cancer	3.71e-05	3.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—liver cancer	3.7e-05	3.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—liver cancer	3.7e-05	3.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	3.69e-05	3.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	3.68e-05	3.69e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—liver cancer	3.67e-05	3.67e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—liver cancer	3.67e-05	3.67e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.67e-05	3.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—liver cancer	3.66e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—liver cancer	3.66e-05	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	3.6e-05	3.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	3.59e-05	3.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	3.57e-05	3.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—liver cancer	3.54e-05	3.54e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PPARG—liver cancer	3.54e-05	3.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—liver cancer	3.5e-05	3.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—liver cancer	3.48e-05	3.48e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—liver cancer	3.45e-05	3.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—liver cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—liver cancer	3.41e-05	3.41e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—liver cancer	3.4e-05	3.41e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—liver cancer	3.37e-05	3.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—liver cancer	3.35e-05	3.35e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—liver cancer	3.34e-05	3.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	3.32e-05	3.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—liver cancer	3.31e-05	3.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—liver cancer	3.29e-05	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—liver cancer	3.29e-05	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	3.28e-05	3.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—liver cancer	3.26e-05	3.27e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.22e-05	3.22e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—liver cancer	3.21e-05	3.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	3.19e-05	3.19e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—liver cancer	3.19e-05	3.19e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—liver cancer	3.18e-05	3.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—liver cancer	3.16e-05	3.16e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—liver cancer	3.15e-05	3.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	3.14e-05	3.14e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—liver cancer	3.12e-05	3.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—liver cancer	3.12e-05	3.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—liver cancer	3.1e-05	3.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—liver cancer	3.09e-05	3.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—liver cancer	3.09e-05	3.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—liver cancer	3.05e-05	3.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—liver cancer	3.05e-05	3.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	3.05e-05	3.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—liver cancer	3.04e-05	3.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—liver cancer	3.04e-05	3.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—liver cancer	3.03e-05	3.03e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—liver cancer	2.99e-05	2.99e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—liver cancer	2.99e-05	2.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—liver cancer	2.95e-05	2.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—liver cancer	2.91e-05	2.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—liver cancer	2.9e-05	2.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—liver cancer	2.83e-05	2.83e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—liver cancer	2.82e-05	2.82e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—liver cancer	2.82e-05	2.82e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.81e-05	2.81e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—liver cancer	2.8e-05	2.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—liver cancer	2.79e-05	2.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	2.79e-05	2.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—liver cancer	2.78e-05	2.78e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—liver cancer	2.76e-05	2.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—liver cancer	2.7e-05	2.7e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—liver cancer	2.68e-05	2.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—liver cancer	2.61e-05	2.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	2.59e-05	2.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—liver cancer	2.58e-05	2.58e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—liver cancer	2.57e-05	2.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—liver cancer	2.57e-05	2.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—liver cancer	2.53e-05	2.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—liver cancer	2.51e-05	2.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—liver cancer	2.47e-05	2.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—liver cancer	2.4e-05	2.4e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—liver cancer	2.37e-05	2.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—liver cancer	2.3e-05	2.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—liver cancer	2.28e-05	2.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—liver cancer	2.12e-05	2.12e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.71e-05	1.71e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—liver cancer	1.4e-05	1.4e-05	CbGpPWpGaD
